ArticleJMIR formative research2024
Acceptance of Medical Artificial Intelligence in Skin Cancer Screening: Choice-Based Conjoint Survey.
Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Preferences for AI-Enabled Health Care Technologies: Systematic Review of Discrete Choice Experiments and Reporting Quality Assessment Using the DIRECT Checklist.Journal of medical Internet research · 2026Pooled it
- Public Preferences for Emerging Cancer Screening Modalities: A Systematic Review of Discrete Choice Experiments.The patient · 2026Pooled it
- Opportunities and challenges of artificial intelligence in public health: a systematic review on technological efficacy, ethical dilemmas, and governance pathways.Frontiers in public health · 2025Pooled it
- The Role of Rating Valence in AI Skin Cancer App Acceptance: Eye-Tracking and Questionnaire Study.JMIR human factors · 2026Article
- Article
- Constructs Influencing Patient Perceptions of Use of AI in Medical Imaging Analysis: Systematic Review.Interactive journal of medical research · 2026Review
- Diagnostic performances of skin cancers using intensity- and gradient-based features with optical coherence tomography: a pilot study.Translational cancer research · 2026Article
- Understanding the Impact of AI Doctors' Information Quality on Patients' Intentions to Adopt AI for Independent Diagnosis: Scenario-Based Experimental Study.Journal of medical Internet research · 2025Article
- Navigating the AI tide: challenges, opportunities, and future directions for early-career dermatologists.Frontiers in medicine · 2025Review
- Digital support and artificial intelligence in cancer patients undergoing radiation therapy: patient utilization, acceptance and attitudes.Frontiers in oncology · 2025Article
- Gender differences in preferences for mental health apps in the general population - a choice-based conjoint analysis from Germany.BMC psychiatry · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is great interest in using artificial intelligence (AI) to screen for skin cancer. This is fueled by a rising incidence of skin cancer and an increasing scarcity of trained dermatologists. AI systems capable of identifying melanoma could save lives, enable immediate access to screenings, and reduce unnecessary care and health care costs. While such AI-based systems are useful from a public health perspective, past research has shown that individual patients are very hesitant about being examined by an AI system.
objectiveThe aim of this study was two-fold: (1) to determine the relative importance of the provider (in-person physician, physician via teledermatology, AI, personalized AI), costs of screening (free, 10€, 25€, 40€; 1€=US $1.09), and waiting time (immediate, 1 day, 1 week, 4 weeks) as attributes contributing to patients' choices of a particular mode of skin cancer screening; and (2) to investigate whether sociodemographic characteristics, especially age, were systematically related to participants' individual choices.
methodsA choice-based conjoint analysis was used to examine the acceptance of medical AI for a skin cancer screening from the patient's perspective. Participants responded to 12 choice sets, each containing three screening variants, where each variant was described through the attributes of provider, costs, and waiting time. Furthermore, the impacts of sociodemographic characteristics (age, gender, income, job status, and educational background) on the choices were assessed.
resultsAmong the 383 clicks on the survey link, a total of 126 (32.9%) respondents completed the online survey. The conjoint analysis showed that the three attributes had more or less equal importance in contributing to the participants' choices, with provider being the most important attribute. Inspecting the individual part-worths of conjoint attributes showed that treatment by a physician was the most preferred modality, followed by electronic consultation with a physician and personalized AI; the lowest scores were found for the three AI levels. Concerning the relationship between sociodemographic characteristics and relative importance, only age showed a significant positive association to the importance of the attribute provider (r=0.21, P=.02), in which younger participants put less importance on the provider than older participants. All other correlations were not significant.
conclusionsThis study adds to the growing body of research using choice-based experiments to investigate the acceptance of AI in health contexts. Future studies are needed to explore the reasons why AI is accepted or rejected and whether sociodemographic characteristics are associated with this decision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.